Hurley Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
21,491
+4,134
+24% +$428K 1.13% 20
2026
Q1
$1.68M Sell
17,357
-43
-0.2% -$4.41K 0.9% 25
2025
Q4
$1.85M Buy
17,400
+457
+3% +$53K 1.03% 26
2025
Q3
$2.15M Buy
16,943
+5
+0% +$595 1.21% 20
2025
Q2
$2.08M Sell
16,938
-483
-3% -$55.2K 1.46% 17
2025
Q1
$1.76M Sell
17,421
-2,805
-14% -$274K 1.34% 18
2024
Q4
$1.84M Buy
+20,226
New +$1.99M 1.48% 20
2015
Q3
$8.52M Buy
234,253
+276
+0.1% +$9.61K 9.89% 2
2015
Q2
$8.57M Sell
233,977
-23,711
-9% -$845K 10.41% 2
2015
Q1
$9.04M Sell
257,688
-46,377
-15% -$1.59M 11.92% 2
2014
Q4
$9.3M Buy
+304,065
New +$9.48M 12.93% 2

Other funds holding EHC

Hurley Capital's EHC Position: Q2 2026 in Review

Hurley Capital increased its Encompass Health (EHC) stake by 24% in Q2 2026, buying an estimated $428K and bringing the position to 21,491 shares worth $2.17M. The position accounts for 1.13% of the portfolio, ranked #20.

Hurley Capital first reported a position in EHC in Q4 2014 and has held it in 11 quarters since. The position peaked at $9.3M in Q4 2014. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Hurley Capital held 21,491 shares of Encompass Health worth $2.17M as of Q2 2026.
  • Hurley Capital bought 4,134 Encompass Health shares in Q2 2026, an estimated $428K.
  • Encompass Health made up 1.13% of Hurley Capital's portfolio in Q2 2026, its #20 holding.
  • Hurley Capital first reported a position in Encompass Health in Q4 2014 and has held it in 11 quarters since.
  • Hurley Capital's Encompass Health position peaked at $9.3M in Q4 2014.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.